» Articles » PMID: 23197295

Activity and Specificity of Necrostatin-1, Small-molecule Inhibitor of RIP1 Kinase

Overview
Specialty Cell Biology
Date 2012 Dec 1
PMID 23197295
Citations 120
Authors
Affiliations
Soon will be listed here.
Citing Articles

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.

Silva-Llanes I, Madruga E, Martinez A, Lastres-Becker I Front Neurosci. 2025; 18:1530809.

PMID: 39931431 PMC: 11808139. DOI: 10.3389/fnins.2024.1530809.


Targeted Degradation of Receptor-Interacting Protein Kinase 1 to Modulate the Necroptosis Pathway.

Inuzuka H, Qian C, Qi Y, Xiong Y, Wang C, Wang Z ACS Pharmacol Transl Sci. 2024; 7(11):3518-3526.

PMID: 39539258 PMC: 11555510. DOI: 10.1021/acsptsci.4c00421.


Downregulation of and mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice.

Song X, Lan Y, Lv S, Wang Y, Chen L, Lu T Front Aging Neurosci. 2024; 16:1401038.

PMID: 38919602 PMC: 11197154. DOI: 10.3389/fnagi.2024.1401038.


Necroptosis in Pneumonia: Therapeutic Strategies and Future Perspectives.

Mei X, Zhang Y, Wang S, Wang H, Chen R, Ma K Viruses. 2024; 16(1).

PMID: 38257794 PMC: 10818625. DOI: 10.3390/v16010094.


Approaches to Evaluating Necroptosis in Virus-Infected Cells.

Lawson C, Titus D, Koehler H Subcell Biochem. 2023; 106:37-75.

PMID: 38159223 DOI: 10.1007/978-3-031-40086-5_2.


References
1.
Teng X, Degterev A, Jagtap P, Xing X, Choi S, Denu R . Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett. 2005; 15(22):5039-44. DOI: 10.1016/j.bmcl.2005.07.077. View

2.
Muller A, DuHadaway J, Donover P, Sutanto-Ward E, Prendergast G . Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med. 2005; 11(3):312-9. DOI: 10.1038/nm1196. View

3.
Christofferson D, Li Y, Hitomi J, Zhou W, Upperman C, Zhu H . A novel role for RIP1 kinase in mediating TNFα production. Cell Death Dis. 2012; 3:e320. PMC: 3388236. DOI: 10.1038/cddis.2012.64. View

4.
Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N . Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2006; 1(2):112-9. DOI: 10.1038/nchembio711. View

5.
Galluzzi L, Vanden Berghe T, Vanlangenakker N, Buettner S, Eisenberg T, Vandenabeele P . Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol. 2011; 289:1-35. DOI: 10.1016/B978-0-12-386039-2.00001-8. View